Australia is closely awaiting the arrival of retatrutide, a groundbreaking dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, https://craigvbwc629996.wikiexcerpt.com/4717039/this_new_drug_retatrutide_australia_a_new_hope_for_weight_management